Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves’ orbitopathy

被引：0
|
作者：
Mariya Asenova Stoynova
Alexander Dimitrov Shinkov
Inna Dimitrova Dimitrova
Inna Angelova Yankova
Roussanka Dimitrova Kovatcheva
机构：
[1] Medical University of Sofia,Department of Endocrinology
[2] University Hospital of Endocrinology,undefined
来源：
International Ophthalmology | 2023年 / 43卷
关键词：
Graves’ orbitopathy; Glucocorticoid regimens; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4747 / 4757
页数：10
相关论文
共 50 条
  • [1] Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves' orbitopathy
    Stoynova, Mariya Asenova
    Shinkov, Alexander Dimitrov
    Dimitrova, Inna Dimitrova
    Yankova, Inna Angelova
    Kovatcheva, Roussanka Dimitrova
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (12) : 4747 - 4757
  • [2] Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves' Orbitopathy
    Campi, Irene
    Vannucchi, Guia
    Muller, Ilaria
    Lazzaroni, Elisa
    Curro, Nicola
    Dainese, Martina
    Montacchini, Benedetta
    Covelli, Danila
    Guastella, Claudio
    Pignataro, Lorenzo
    Fugazzola, Laura
    Arosio, Maura
    Salvi, Mario
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12
  • [3] Treatment of moderate-to-severe and active Graves' orbitopathy: a step forward from the OPTIC study
    Tanda, M. L.
    Gallo, D.
    Ippolito, S.
    Bartalena, L.
    Piantanida, E.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (10) : 1523 - 1525
  • [4] Treatment of moderate-to-severe and active Graves’ orbitopathy: a step forward from the OPTIC study
    M. L. Tanda
    D. Gallo
    S. Ippolito
    L. Bartalena
    E. Piantanida
    Journal of Endocrinological Investigation, 2020, 43 : 1523 - 1525
  • [5] Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications
    Urselli, Francesca
    Pontieri, Gilda
    Peschi, Livia
    Liccardi, Alessia
    Ruggiero, Anna Rita
    Biondi, Bernadette
    FRONTIERS IN ENDOCRINOLOGY, 2019, 9
  • [6] Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves' orbitopathy?
    Piantanida, E.
    Bartalena, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (08): : 885 - 887
  • [7] Methotrexate plus reduced or full-dose glucocorticoids for the treatment of active, moderate-to-severe Graves' orbitopathy
    Shen, Liyun
    Ye, Lei
    Zhu, Wei
    Jiao, Qin
    Zhou, Yulin
    Wang, Shu
    Wang, Weiqing
    Ning, Guang
    EUROPEAN THYROID JOURNAL, 2022, 11 (05)
  • [8] Comparative effectiveness of different treatment modalities for active, moderate-to-severe Graves' orbitopathy: a systematic review and network meta-analysis
    Li, Hongxun
    Yang, Lihong
    Song, Yi
    Zhao, Xinheng
    Sun, Chunhua
    Zhang, Lei
    Zhao, Hong
    Pan, Ye
    ACTA OPHTHALMOLOGICA, 2022, 100 (06) : E1189 - E1198
  • [9] Efficacy of orbital radiotherapy in moderate-to-severe active graves’ orbitopathy including long-lasting disease: a retrospective analysis
    Jin Hwa Choi
    Jeong Kyu Lee
    Radiation Oncology, 15
  • [10] Efficacy of orbital radiotherapy in moderate-to-severe active graves' orbitopathy including long-lasting disease: a retrospective analysis
    Choi, Jin Hwa
    Lee, Jeong Kyu
    RADIATION ONCOLOGY, 2020, 15 (01)
12345